Stanford University's Stephen Quake tells the New York Times that he encouraged CRISPR researcher He Jiankui to seek the proper ethical approvals.
Science reports that researchers have found a way to use CRISPR on lizard embryos.
In PLOS this week: 'reverse genome-wide association study' method; genetic links between Familial Mediterranean Fever and ankylosing spondylitis; and more.
In Science this week: genomic study of convergent evolution of the loss of flight in birds, and more.
In Nature this week: analysis of gut microbiome of colorectal cancer patients, enzymes that block CRISPR editing, and more.
The firm originally raised $55.5 million in the round in February 2018, and said investors added $30 million in December and another $20 million more recently.
The company plans to sell 7.9 million shares of common stock at $16 per share through its initial public offering.
In Nature this week: GWAS of cigarette smoking behaviors, set of gene expression predictors for schizophrenia, and more.
Harvard Medical School's George Church and his colleagues report in a preprint that they made more than 13,000 genome edits to a single cell.
The company has initial financing of $35 million, and has licensed its foundational SHERLOCK and INSPECTR technologies from the Broad and Harvard, respectively.
Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.
Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.
The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.
In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.